India-US Trade Deal Is 99% Done. Here Is What It Means for NRIs.
Trump says the US-India trade deal is 'very close.' 99% agreed per the US Ambassador. Agriculture and dairy are the last sticking point. Here is what the deal means for NRI businesses, FDI, and the rupee.
At the G7 summit in France on June 17, Donald Trump said the United States and India are "very close" to finalising a trade deal. US Ambassador to India Sergio Gor went further the same week: 99% of the bilateral agreement is in place. Negotiators are working through the final technical and legal drafting in New Delhi.
The one remaining sticking point is the one that has blocked every US-India trade deal for decades: agriculture. Specifically, US demands for access to India's dairy market and removal of barriers on GMO crops. India has not moved on this in any prior negotiation. Whether it moves now is the question that determines whether "99% done" becomes 100%.
For NRIs with businesses, investments, or financial ties across both countries, the deal's proximity to closing is the most important trade-policy development in years.
The 30-second answer: The India-US interim trade deal is the most advanced it has ever been — 99% agreed per the US Ambassador, with Trump and Modi meeting at the G7. The first tranche covers tariff reduction on goods (Indian exports to the US face 10-26% tariffs currently), investment facilitation, and customs simplification. For NRIs: (1) exporters and importers with cross-border goods businesses should model the tariff impact now — lower US tariffs on Indian goods will improve margins for Indian-export businesses; (2) the deal is net positive for the rupee — a stronger India-US trade corridor improves FDI flows and reduces trade friction; (3) agriculture/dairy is the last sticking point — if India concedes on dairy access, the deal signs; if not, expect a further delay of 3-6 months. For most NRIs, the deal's biggest practical effect is a stronger India growth story, which supports Indian equity and the rupee over 12-24 months.
What is actually agreed
The India-US Interim Trade Agreement is being structured as a first tranche of a larger Bilateral Trade Agreement (BTA). Negotiators chose the tranche approach because a comprehensive BTA would take 3-5 years to negotiate, and both governments wanted to show progress before the 2026 US election cycle heats up.
The confirmed elements:
Tariff reductions on goods: The US imposed sweeping reciprocal tariffs on Indian goods in early 2025 — ranging from 10% on electronics and pharmaceuticals to 26% on textiles and apparel. The deal is expected to reduce or eliminate these for specified categories. In return, India will reduce tariffs on US goods in categories where both sides have agreed, which reportedly includes certain agricultural products (not dairy) and high-value manufactured goods.
Investment facilitation: Simplified approval processes for US direct investment in India, including faster regulatory clearances, stronger intellectual property enforcement, and removal of local content requirements in several sectors. This is important for NRI entrepreneurs who structure investment through US entities.
Customs and trade facilitation: Mutual recognition of customs procedures, faster clearance for goods in transit, and reduced documentation requirements. For NRI businesses that import or export, this reduces the transactional cost of cross-border trade.
Services: Limited provisions on services trade, including acknowledgement of mutual interest in professional services mobility. Not a visa expansion, but a framework for further discussion.
What is not agreed
Agriculture and dairy: India imports minimal dairy products and has significant political sensitivity around protecting its dairy farmers. The US has pushed for elimination of India's tariffs on US dairy (currently 30-60%) and approval of GMO crops. India's Commerce Minister Piyush Goyal has described this as a red line. Negotiators may find a middle ground — token access on a small category of US dairy products — that allows both sides to claim a win without genuinely opening India's dairy market. Whether that is enough for the US to declare the deal signed is unclear.
The NRI business angle
If you run an India-export business (textiles, pharma, engineering, gems):
The tariff reduction on Indian goods entering the US is the most direct financial impact. Indian textiles currently face 26% US tariffs — a deal that brings this down to 10-15% meaningfully improves the economics of selling in the US market. Run the model now with different tariff scenarios. If your business has been constrained by US tariff costs, the deal changes the competitive picture materially.
Pharmaceutical exports are a more complicated case. Indian pharma exports to the US largely occur through FDA-approved manufacturing and are subject to separate regulatory frameworks, not just tariffs. The trade deal will not eliminate the FDA approval process, but if it reduces or eliminates the Section 232 tariffs that have applied to some Indian pharma products, it helps.
If you run a US business that sells to India:
The deal likely increases competition in India for whatever US goods India agrees to reduce tariffs on. If you sell US manufactured goods in India — machinery, electronics, agricultural inputs — the competitive landscape changes as US products become cheaper to import. This is a headwind for India-based distribution businesses.
If you are an NRI investor or entrepreneur looking to invest in India:
The investment facilitation provisions are the relevant part. Simpler regulatory approval, stronger IP enforcement, and faster repatriation of profits are exactly the friction points that have historically made NRI entrepreneurs route investment through Mauritius or Singapore holding structures rather than direct FDI. If the deal reduces that friction, it makes a direct India investment structure more attractive.
The rupee and macro implications
A signed India-US trade deal would be a significant positive for the Indian rupee and broader India equity over 12-24 months, for three reasons.
First, FDI inflows. A trade deal increases US investor confidence in India's regulatory environment and predictability. FDI follows trade agreements — the same pattern played out after India's FTAs with the UAE and Australia. US FDI into India has been constrained by tariff uncertainty and regulatory friction. Removing both should increase inflows, which strengthens the rupee.
Second, export revenue. Lower US tariffs on Indian goods means more Indian exports, which means more dollars flowing into India from trade. India's current account deficit, which has been the primary driver of rupee weakness, narrows as export revenues rise.
Third, sentiment and rating. A formalised India-US trade partnership raises India's profile as a stable, rule-of-law investment destination. This is the kind of macro narrative that brings foreign institutional investors back to Indian equities.
The combined effect: positive for the rupee, positive for Indian equities, and positive for NRIs with long-term India exposure.
The agriculture sticking point: what it means for the timeline
The deal's signature depends on whether India concedes something on dairy and agriculture that the US can present as a win to its own dairy lobby.
Three scenarios:
Scenario 1 — Token concession (most likely): India agrees to a small quota of duty-free US dairy imports — say, 5,000 tonnes per year against India's total dairy output of 230 million tonnes. The US accepts this as a symbolic opening. Deal signs within 4-6 weeks.
Scenario 2 — No concession, deal signs anyway: Both sides agree to leave agriculture entirely for the comprehensive BTA and sign the interim agreement on the agreed 99%. This is possible given political will on both sides, but the US dairy lobby has been influential in blocking India trade deals before.
Scenario 3 — Agriculture blocks the deal: India refuses any dairy concession, US domestic politics make it impossible to sign without one, deal is delayed 3-6 months into the US election season. This is the risk scenario.
Markets are currently pricing Scenario 1. The Indian equity market's brief strength on June 17 on the Trump-Modi G7 meeting reflects optimism that the finish line is close.
The closing read
The India-US trade deal is the closest it has ever been to signature — which, given the twenty-year history of failed attempts, is genuinely significant. For NRIs with cross-border business exposure, the window to prepare is now: model the tariff scenarios, review your India investment structures for investment facilitation benefits, and factor a stronger India macro into your 12-24 month equity and rupee assumptions. The agriculture sticking point is real but manageable. Watch for a signing announcement in the next 4-8 weeks. If it comes, it will be a positive macro event for India that reinforces the oil deal's already-favourable tailwind.
Related reading
- Oil at $80: What the Iran Deal Means for India's Rupee
- Nifty 24,000: NRI India Equity Playbook
- RBI FEMA Reform: NRI Repatriable Investment Accounts
- Fed Rate Hike Signal: NRI Deposit Strategy
- NRE vs NRO vs FCNR: Which Account for Which Purpose
- India Sovereign Rating Upgrade 2026: NRI Impact
- DTAA India-US: Avoiding Double Tax on US Income
- NRI LRS: Global Investing from India Under the Liberalised Remittance Scheme
Sources: Bloomberg, "Trump Says US, India 'Very Close' to Finalizing Trade Deal After Modi Meeting," June 17, 2026; Deccan Chronicle, "US Trade Team Arrives in India for Key Talks on Interim Trade Deal"; Outlook India, "India-US Trade Deal Nears Completion as Piyush Goyal Says All Major Points Settled"; BivashVlog, "India US Trade Deal 2026: 8 Critical Facts After June Talks Conclude."
Disclaimer: Trade deal terms are subject to change until formally signed. This article is for general information only and does not constitute legal or business advice. Verify current tariff rates and deal status before making business decisions.
Frequently asked questions
What is the India-US trade deal 2026 and what does it cover?
The India-US Interim Trade Agreement of 2026 is a bilateral trade deal that has been in negotiation since early 2025, when the Trump administration imposed reciprocal tariffs on Indian goods. The interim agreement covers three main areas: tariff reduction on goods (both ways), improved market access for US services and agricultural products in India, and investment facilitation measures including customs simplification and intellectual property protections. The deal is structured as an interim agreement — a first tranche — while a comprehensive Bilateral Trade Agreement (BTA) is negotiated separately, which may take 2-3 years. The most politically sensitive item remaining is US demands for access to India's dairy and agricultural markets, where India has historically resisted foreign competition. US Ambassador Sergio Gor confirmed as of mid-June 2026 that 99% of the deal is agreed, with technical and legal drafting underway. Trump confirmed on June 17 that the US and India are 'very close' to finalising the agreement after his meeting with Prime Minister Modi at the G7 summit.
How does the India-US trade deal affect NRIs with businesses in India or the US?
The India-US trade deal has different implications depending on what your business does. NRIs running US businesses that import from India benefit directly from lower Indian export tariffs — goods like textiles, pharmaceuticals, engineering products, and gems and jewellery that India exports to the US currently face tariffs in the 10-26% range. The deal is expected to reduce these materially. NRIs running India-based businesses that export to the US see the same benefit: lower US tariffs on Indian goods make Indian products more competitive, increasing export volumes and margins. NRIs in the services sector — IT, consulting, finance — are less directly affected by tariff changes, but the deal includes services provisions that may ease H-1B visa processing and remove some non-tariff barriers. NRI-owned businesses importing US goods into India (agriculture, machinery, electronics) may face a more competitive environment if Indian tariffs on US products fall as part of the reciprocal structure.
Does the India-US trade deal affect H-1B visas or NRI professionals working between the two countries?
Trade deals typically include provisions on the movement of professionals, but these are usually modest and do not fundamentally change visa quotas or eligibility. The India-US deal as currently described covers goods trade, investment facilitation, and customs — not immigration. H-1B visa policy is set separately by Congress and the USCIS. However, a trade deal with India would create a stronger diplomatic context for bilateral discussions on professional mobility, and both countries have separately signalled interest in addressing visa processing delays and expanding the professional movement framework. The practical outcome for NRIs: do not expect H-1B quota increases or dramatically faster processing from the trade deal itself. What may change over time is the regulatory environment for Indian-origin professionals starting or investing in US businesses — the investment facilitation provisions may make it easier for NRI entrepreneurs to access Indian government contracts, set up joint ventures, and repatriate profits.
Rakesh Sinha, NRI Finance Writer
Rakesh Sinha is a technology professional and an NRI since 2016. He holds a master’s from Carnegie Mellon University and a BTech in Computer Science from IIT Guwahati, and has worked at Microsoft, Cisco, InMobi and Google across Bengaluru, the United States and London. He has personally navigated the decisions these guides cover: moving foreign salary and tech-company RSUs across borders, opening NRE, NRO and FCNR accounts, filing Indian returns as a non-resident, and claiming DTAA relief between the US, UK and India. How these guides are written and reviewed.
Disclaimer: This guide is educational and general in nature. It is not individual financial, tax, or legal advice. Tax and FEMA rules change and your situation may differ, so confirm specifics with a qualified chartered accountant or financial adviser before acting. See our editorial standards for how these guides are researched, reviewed and updated.